{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:06:40Z","timestamp":1784282800976,"version":"3.55.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02717","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T07:19:14Z","timestamp":1574407154000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal \u03b3\u03b4 Memory T Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Vinicia A.","family":"Polito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Cristantielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Del Bufalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamascia","family":"Belardinilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Arnone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Petretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pitisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Quintarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1200\/JCO.2000.18.18.3273","article-title":"Late effects of treatment in survivors of childhood acute myeloid leukemia","volume":"18","author":"Leung","year":"2000","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","article-title":"An overview of infectious complications after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Sahin","year":"2016","journal-title":"J Infect Chemother"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.4161\/cbt.8.16.8950","article-title":"Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood","volume":"8","author":"Kang","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/10428190500051893","article-title":"Anti-lymphoma effect of gammadelta T cells","volume":"46","author":"Kunzmann","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e49878","DOI":"10.1371\/journal.pone.0049878","article-title":"Characterization of human gammadelta T lymphocytes infiltrating primary malignant melanomas","volume":"7","author":"Cordova","year":"2012","journal-title":"PLoS ONE"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/cmi.2012.39","article-title":"What lessons can be learned from gammadelta T cell-based cancer immunotherapy trials?","volume":"10","author":"Fournie","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","article-title":"gammadelta T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-alphabeta+\/CD19+ lymphocytes","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0923-2494(96)89649-0","article-title":"Direct presentation of non-peptide prenyl pyrophosphate antigens to human gamma delta T cells","volume":"147","author":"Morita","year":"1996","journal-title":"Res Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.4049\/jimmunol.176.3.1386","article-title":"Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation","volume":"176","author":"Devilder","year":"2006","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4049\/jimmunol.174.1.252","article-title":"Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines","volume":"174","author":"Conti","year":"2005","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2781","article-title":"Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity","volume":"10","author":"Bonneville","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1182\/blood.V96.12.3827","article-title":"CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies","volume":"96","author":"Lopez","year":"2000","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/0032472031000141295","article-title":"Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effect","volume":"1","author":"Lamb","year":"1999","journal-title":"Cytotherapy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e4909","DOI":"10.1097\/MD.0000000000004909","article-title":"In vivo expansion and activation of gammadelta T cells as immunotherapy for refractory neuroblastoma: a phase 1 study","volume":"95","author":"Pressey","year":"2016","journal-title":"Medicine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1080\/14653240802419328","article-title":"Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy","volume":"10","author":"Kondo","year":"2008","journal-title":"Cytotherapy"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1216291","DOI":"10.1080\/2162402X.2016.1216291","article-title":"Zoledronic acid boosts gammadelta T-cell activity in children receiving alphabeta(+) T and CD19(+) cell-depleted grafts from an HLA-haplo-identical donor","volume":"6","author":"Bertaina","year":"2017","journal-title":"Oncoimmunology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00262-010-0887-0","article-title":"Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients","volume":"59","author":"Cabillic","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00262-011-1049-8","article-title":"Pilot trial of interleukin-2 and zoledronic acid to augment gammadelta T cells as treatment for patients with refractory renal cell carcinoma","volume":"60","author":"Lang","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","article-title":"Delta one T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion\/differentiation and preclinical proof of concept","volume":"22","author":"Almeida","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ymthe.2017.12.001","article-title":"Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation","volume":"26","author":"Capsomidis","year":"2018","journal-title":"Mol Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3109\/14653249.2011.553595","article-title":"Human Vdelta1 gammadelta T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells","volume":"13","author":"Siegers","year":"2011","journal-title":"Cytotherapy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1158\/1078-0432.CCR-13-3451","article-title":"Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies","volume":"20","author":"Deniger","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1158\/1078-0432.CCR-13-3464","article-title":"Neuroblastoma killing properties of Vdelta2 and Vdelta2-negative gammadeltaT cells following expansion by artificial antigen-presenting cells","volume":"20","author":"Fisher","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nm.3833","article-title":"Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes","volume":"21","author":"Caruana","year":"2015","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1158\/1078-0432.CCR-14-2998","article-title":"K562-derived whole-cell vaccine enhances antitumor responses of CAR-redirected virus-specific cytotoxic T lymphocytes in vivo","volume":"21","author":"Caruana","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/1078-0432.CCR-13-2218","article-title":"T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo","volume":"20","author":"Geldres","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1053\/j.seminoncol.2014.08.005","article-title":"From monoclonal antibodies to chimeric antigen receptors for the treatment of human malignancies","volume":"41","author":"Caruana","year":"2014","journal-title":"Semin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1433518","DOI":"10.1080\/2162402X.2018.1433518","article-title":"Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma","volume":"7","author":"Quintarelli","year":"2018","journal-title":"Oncoimmunology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1378843","DOI":"10.1080\/2162402X.2017.1378843","article-title":"Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model","volume":"7","author":"Bocca","year":"2017","journal-title":"Oncoimmunology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1158\/1078-0432.CCR-13-0955","article-title":"Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia\u2013implications for immunotherapy","volume":"19","author":"Weber","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/leu.2013.66","article-title":"Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant","volume":"27","author":"Weber","year":"2013","journal-title":"Leukemia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/leu.2009.70","article-title":"WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation","volume":"23","author":"Weber","year":"2009","journal-title":"Leukemia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1158\/0008-5472.CAN-14-0697","article-title":"Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors","volume":"74","author":"Nishio","year":"2014","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat Methods"},{"key":"B36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cels.2016.11.005","article-title":"Elucidation of signaling pathways from large-scale phosphoproteomic data using protein interaction networks","volume":"3","author":"Rudolph","year":"2016","journal-title":"Cell Syst"},{"key":"B37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2017.03.008","article-title":"Current modalities in cancer immunotherapy: immunomodulatory antibodies, CARs and vaccines","volume":"178","author":"Lohmueller","year":"2017","journal-title":"Pharmacol Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1182\/blood-2011-05-354449","article-title":"Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma","volume":"118","author":"Louis","year":"2011","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","article-title":"HER2-Specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial","volume":"3","author":"Ahmed","year":"2017","journal-title":"JAMA Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/mt.2016.72","article-title":"Overcoming challenges in CAR T-cell product CGMP release","volume":"24","author":"Quintarelli","year":"2016","journal-title":"Mol Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of gammadelta T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2014.00344","article-title":"Expanded human blood-derived gammadeltaT cells display potent antigen-presentation functions","volume":"5","author":"Khan","year":"2014","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e68729","DOI":"10.1371\/journal.pone.0068729","article-title":"CMV-independent lysis of glioblastoma by ex vivo expanded\/activated Vdelta1+ gammadelta T cells","volume":"8","author":"Knight","year":"2013","journal-title":"PLoS ONE"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/mt.2014.104","article-title":"Cytotoxic and regulatory properties of circulating Vdelta1+ gammadelta T cells: a new player on the cell therapy field?","volume":"22","author":"Siegers","year":"2014","journal-title":"Mol Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2217\/imt.09.27","article-title":"\u03b3\u03b4T cells in cancer immunotherapy: current status and future prospects","volume":"1","author":"Chiplunkar","year":"2009","journal-title":"Immunotherapy"},{"key":"B49","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ni.2394","article-title":"Cytomegalovirus and tumor stress surveillance by binding of a human gammadelta T cell antigen receptor to endothelial protein C receptor","volume":"13","author":"Willcox","year":"2012","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/gt.2009.6","article-title":"Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes","volume":"16","author":"Hiasa","year":"2009","journal-title":"Gene Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nri.2017.101","article-title":"gammadelta T cells in homeostasis and host defence of epithelial barrier tissues","volume":"17","author":"Nielsen","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1158\/2326-6066.CIR-17-0126","article-title":"Reversible transgene expression reduces fratricide and permits 4\u20131BB costimulation of CAR T cells directed to T-cell malignancies","volume":"6","author":"Mamonkin","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3389\/fimmu.2018.02636","article-title":"Tissue adaptations of memory and tissue-resident gamma delta T cells","volume":"9","author":"Khairallah","year":"2018","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1158\/1078-0432.CCR-09-2046","article-title":"K562\/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate","volume":"16","author":"Smith","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3389\/fimmu.2014.00645","article-title":"Human peripheral CD4(+) Vdelta1(+) gammadeltaT cells can develop into alphabetaT cells","volume":"5","author":"Ziegler","year":"2014","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.4049\/jimmunol.0901017","article-title":"Protumor vs antitumor functions of IL-17","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T07:19:21Z","timestamp":1574407161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2019.02717"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02717","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"article-number":"2717"}}